Skip to main navigation Skip to search Skip to main content

Cabozantinib in prostate cancer: The beginning of a precision paradigm?

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)401-403
Number of pages3
JournalJournal of Clinical Oncology
Volume31
Issue number4
DOIs
StatePublished - Feb 1 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Cabozantinib in prostate cancer: The beginning of a precision paradigm?'. Together they form a unique fingerprint.

Cite this